{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:43:16Z","timestamp":1787766196596,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016309","name":"Bayer, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V037633\/1"],"award-info":[{"award-number":["MR\/V037633\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.rpth.2025.102954","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:31:41Z","timestamp":1750793501000},"page":"102954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome\u2014insights from a UK center"],"prefix":"10.1016","volume":"9","author":[{"given":"Giulia","family":"Simini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Vinayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golzar","family":"Mobayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanthi","family":"Karawitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Claudiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Odho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5993-4850","authenticated-orcid":false,"given":"Deepa J.","family":"Arachchillage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102954_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.rpth.2025.102954_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ajh.24293","article-title":"Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients","volume":"91","author":"Haider","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102954_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajh.23135","article-title":"Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Tefferi","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102954_bib5","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpth.2025.102954_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00277-016-2826-4","article-title":"Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey","volume":"96","author":"Koren-Michowitz","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.102954_bib7","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/cancers12071746","article-title":"Essential thrombocythemia and acquired von Willebrand syndrome: the shadowlands between thrombosis and bleeding","volume":"12","author":"Awada","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2025.102954_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/beha.2001.0141","article-title":"Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management","volume":"14","author":"Michiels","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.20452\/pamw.3211","article-title":"Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients","volume":"125","author":"Mital","year":"2015","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.rpth.2025.102954_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.thromres.2015.07.029","article-title":"Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera\u2013retrospective analysis of 142 consecutive cases","volume":"136","author":"Mital","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102954_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08858.x","article-title":"Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients","volume":"156","author":"Palandri","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","article-title":"Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.rpth.2025.102954_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2141.2010.08122.x","article-title":"Guideline for investigation and management of adults and children presenting with a thrombocytosis","volume":"149","author":"Harrison","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bjh.15647","article-title":"A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: a British Society for Haematology Guideline","volume":"184","author":"McMullin","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib15","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S2352-3026(22)00046-1","article-title":"Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations","volume":"9","author":"Marchetti","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2006-05-025544","article-title":"Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11899-021-00649-x","article-title":"Management Issues and controversies in low-risk patients with essential thrombocythemia and polycythemia vera","volume":"16","author":"How","year":"2021","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.rpth.2025.102954_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ajh.21730","article-title":"Polycythemia vera-associated acquired von Willebrand syndrome despite near-normal platelet count","volume":"85","author":"Tefferi","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.102954_bib19","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.11.011","article-title":"Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera","volume":"41","author":"Rottenstreich","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2025.102954_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ijlh.14074","article-title":"Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease","volume":"45","author":"Smock","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2025.102954_bib22","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109094","article-title":"Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay","volume":"241","author":"Hamiko","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102954_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jtha.2023.12.024","article-title":"Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype","volume":"22","author":"Noye","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1538-7836.2012.04747.x","article-title":"Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib27","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib29","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib31","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V84.10.3378.3378","article-title":"Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen","volume":"84","author":"van Genderen","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hon.2903","article-title":"Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis","volume":"39","author":"Trotti","year":"2021","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.rpth.2025.102954_bib33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","article-title":"Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome","volume":"68","author":"Budde","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102954_bib34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/jth.15717","article-title":"Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia","volume":"20","author":"Kubo","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib35","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/jth.12967","article-title":"Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count","volume":"13","author":"Lancellotti","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102954_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/bjh.13438","article-title":"Acquired factor V deficiency in myeloproliferative neoplasms: a Mayo Clinic series of 33 patients","volume":"171","author":"Ashrani","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.102954_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/M17-0284","article-title":"Benefits and risks of antithrombotic therapy in essential thrombocythemia: a systematic review","volume":"167","author":"Chu","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792500278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:13:57Z","timestamp":1777634037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792500278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S247503792500278X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102954","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome\u2014insights from a UK center","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102954"}}